M&A Deal Summary |
|
---|---|
Date | 2024-04-10 |
Target | SaveWay |
Sector | Life Science |
Buyer(s) | Myonexus Therapeutics |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2017 |
Sector | Life Science |
Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb girdle muscular dystrophies (LGMDs) based on research at Nationwide Children’s Hospital, a provider in neuromuscular gene therapy discovery and translational research. Myonexus Therapeutics was founded in 2017 and is based in New Albany, Ohio.
DEAL STATS | # |
---|---|
Overall | 2 of 2 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Delaware) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2024) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-03-15 |
Creapharm’s Clinical & Commercial Packaging and Bioservices Business
Reims, France Creapharm’s Clinical & Commercial Packaging and Bioservices Business provides clinical packaging and distribution to commercial packaging and advanced therapy medicinal products (ATMPs) supply chain management. |
Buy | - |